Co-Diagnostics, Inc. to Present at Sidoti Summer Small Cap Virtual Conference

Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq: CODX) announced that key executives will participate in the Sidoti Summer Small Cap Virtual Investor Conference on June 15-16, 2022. CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson will present and hold one-on-one meetings with investors. The presentation starts at 3:15 p.m. EDT on June 15 and can be accessed via the company's website. Co-Diagnostics specializes in molecular diagnostics, focusing on developing tests that analyze nucleic acid molecules for various applications, including infectious diseases.

SALT LAKE CITY, June 15, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx,"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Dwight Egan, CEO, Brian Brown, CFO, and Andrew Benson, Head of Investor Relations, will present and host one-on-one meetings with investors at the Sidoti Summer Small Cap Virtual Investor Conference June 15-16, 2022.

The presentation will begin at 3:15 p.m. EDT on Wednesday June 15, 2022, and can be accessed on the Events and Webcasts section of the Co-Diagnostics website. To register for the presentation or one-on-ones, please visit www.sidoti.com/events.

About Co-Diagnostics, Inc.:

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-present-at-sidoti-summer-small-cap-virtual-conference-301568436.html

SOURCE Co-Diagnostics

FAQ

When will Co-Diagnostics present at the Sidoti Summer Small Cap Virtual Investor Conference?

Co-Diagnostics will present on June 15, 2022, at 3:15 p.m. EDT.

Who will represent Co-Diagnostics at the Sidoti Summer Small Cap Virtual Investor Conference?

Dwight Egan (CEO), Brian Brown (CFO), and Andrew Benson (Head of Investor Relations) will represent the company.

How can investors access the Co-Diagnostics presentation?

Investors can access the presentation through the Events and Webcasts section on the Co-Diagnostics website.

What is the focus of Co-Diagnostics, Inc.?

Co-Diagnostics specializes in molecular diagnostics, developing tests that analyze DNA or RNA for various applications.

What is the stock symbol for Co-Diagnostics?

The stock symbol for Co-Diagnostics is CODX.